Taysha Gene Therapies: CLN1 KOL Webinar
|DATE:||August 30, 2021|
|TIME:||12:00 AM EDT|
About The Event
Please join us for the Taysha Gene Therapies CLN1 KOL Webinar on Monday, August 30th from 10:00 AM – 12:30 PM EDT. The event will feature a presentation from Key Opinion Leader Angela Schulz, M.D., Ph.D., University Medical Center Hamburg-Eppendorf, who will provide an overview of CLN1 disease, a severe, neurodegenerative lysosomal storage disease with no approved treatment, and review patient natural history.
- Steven Gray, Ph.D., Associate Professor in the department of Pediatrics at UT Southwestern and Chief Scientific Advisor at Taysha, will review the preclinical and pharmacology data for TSHA-118 for the treatment of CLN1 disease
- Sharon King, President of Taylor’s Tale, will discuss the burden of disease and provide a patient and caregiver perspective
- Suyash Prasad, MBBS, M.Sc., MRCP, MRCPCH, FFPM, CMO and Head of R&D of Taysha, will discuss the clinical development strategy
Q&A will follow each formal presentation.